How We Die, Then and Now - The Need for Preventive Medicine -- By Avi Roy (President, Biogerontology Research Foundation)

Avi Roy commenced the Second Big Data Science in Medicine Symposium by discussing changes in ‘How we Die: Then and Now’, and highlighting the need to accelerate research into preventive medicine. 


Stephen Sackur (Presenter HARDtalk, BBC) One-on-One: an investigative interview with Aubrey de Grey (Chief Science Officer & Co-Founder, SENS Research Foundation)

The St. Gallen Symposium is a global gathering of Leaders of Today and Tomorrow that takes place annually in May at the University of St. Gallen, Switzerland. It is organised by the International Students’ Committee (ISC), a team of students from the university. Its goal is to provide a setting for relevant debates between Leaders of Today and Tomorrow on topics of management, politics and civil society. SENS Research Foundation's chief science officer, Dr. Aubrey de Grey, was invited to give an in-depth interview at the 2014 Symposium with veteran journalist Stephen Sackur of the BBC. The conversation covers a wide range of topics related to the approaching era of greatly extended human health- and lifespans - we think it's one of Aubrey's most comprehensive and entertaining presentations to date.


A Cure for Ageing?: David Sinclair at TEDxSydney

Can we really cure ageing? David Sinclair thinks so, and he's going to try to prove it.

David Sinclair is a scientist and entrepreneur working on increasing human health, productivity, and lifespan. After co-discovering a molecular cause of aging at the Massachusetts Institute in Boston in the mid-1990s, he joined the faculty of Harvard Medical School where he is now a tenured Professor. In 2005, he founded the Glenn Laboratories for Aging Research at Harvard and serves as their Co-Director. He is also a Professor at the Lowy Cancer Centre at the University of New South Wales, Sydney.

His research is aimed at understanding why we grow old and using this knowledge to prevent and treat both rare and common diseases. He is perhaps best known for identifying resveratrol from red wine as an anti-aging molecule. He has founded four biotechnology companies; to treat age-related diseases (Sirtris), improve female reproductive health and IVF (OvaScience), treat type 2 diabetes (Cohbar), and develop vaccines against malaria, chlamydia, tuberculosis, pneumonia, and cancer (Genocea).